Literature DB >> 7825523

Dietary supplementation with n-3 fatty acids increases gluconeogenesis from glycerol but not hepatic glucose production in patients with non-insulin-dependent diabetes mellitus.

I Puhakainen1, I Ahola, H Yki-Järvinen.   

Abstract

Fish-oil supplementation decreases serum triacylglycerols but may worsen hyperglycemia in patients with non-insulin-dependent diabetes mellitus. The reason for the possible deterioration of glycemia is unclear. We examined whether inhibition of triacylglycerol synthesis by n-3 fatty acids changes lipolysis, glycerol gluconeogenesis, or fatty acid oxidation. Nine obese patients with non-insulin-dependent diabetes mellitus participated in a randomized double-blind crossover study in which 6 wk of n-3 fatty acid supplementation (12 g fish oil) was compared with 6 wk of corn plus olive oil. Serum triacylglycerols decreased by 30% during n-3 fatty acid supplementation. Glycerol gluconeogenesis ([U-14C]glycerol) increased by 32%. However, overall glucose production ([3-3H]glucose), glycemic control, and fatty acid oxidation remained unchanged. Thus, 6 wk of n-3 fatty acid supplementation lowers triacylglycerols in patients with non-insulin-dependent diabetes mellitus without worsening glycemic control. However, n-3 fatty acid supplementation increases glycerol gluconeogenesis, which could contribute to deterioration of glycemic control during long-term treatment with high doses of fish-oil supplements.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7825523     DOI: 10.1093/ajcn/61.1.121

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  16 in total

Review 1.  Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials.

Authors:  Akintunde O Akinkuolie; Julius S Ngwa; James B Meigs; Luc Djoussé
Journal:  Clin Nutr       Date:  2011-09-29       Impact factor: 7.324

2.  Plasma fatty acids as predictors of glycaemia and type 2 diabetes.

Authors:  Maria A Lankinen; Alena Stančáková; Matti Uusitupa; Jyrki Ågren; Jussi Pihlajamäki; Johanna Kuusisto; Ursula Schwab; Markku Laakso
Journal:  Diabetologia       Date:  2015-08-16       Impact factor: 10.122

Review 3.  n-3 fatty acids and lipoproteins: comparison of results from human and animal studies.

Authors:  W S Harris
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  The effects of omega-3 plus vitamin E and zinc plus vitamin C supplementation on cardiovascular risk markers in postmenopausal women with type 2 diabetes.

Authors:  Mohammad Reza Mahmoodi; Masoud Kimiagar; Yadollah Mehrabi
Journal:  Ther Adv Endocrinol Metab       Date:  2014-08       Impact factor: 3.565

5.  Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial.

Authors:  Feng Wang; Yanyan Wang; Yan Zhu; Xiaosong Liu; Hui Xia; Xian Yang; Guiju Sun
Journal:  Eur J Nutr       Date:  2016-12-02       Impact factor: 5.614

6.  Role of Omega-3 Fatty Acids on Lipid Profile in Diabetic Dyslipidaemia: Single Blind, Randomised Clinical Trial.

Authors:  Shaylika Chauhan; Hanish Kodali; Jawad Noor; Karuna Ramteke; Vidisha Gawai
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus.

Authors:  Manas Kaushik; Dariush Mozaffarian; Donna Spiegelman; JoAnn E Manson; Walter C Willett; Frank B Hu
Journal:  Am J Clin Nutr       Date:  2009-07-22       Impact factor: 7.045

Review 8.  Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jason H Y Wu; Leah E Cahill; Dariush Mozaffarian
Journal:  J Clin Endocrinol Metab       Date:  2013-05-23       Impact factor: 5.958

Review 9.  Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.

Authors:  J Hartweg; A J Farmer; R Perera; R R Holman; H A W Neil
Journal:  Diabetologia       Date:  2007-05-31       Impact factor: 10.122

Review 10.  Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.

Authors:  J Hartweg; R Perera; V Montori; S Dinneen; H A W Neil; A Farmer
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.